GALILEO PHARMACEUTICALS

Galileo Pharmaceuticals, Inc. is focused on the discovery and development of small molecule therapeutics to treat metabolic diseases
Similar Organizations
Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology.
Avvinity
Avvinity was established as a Joint Venture between Horizon Discovery and Centauri Therapeutics.
Biotherapies
Biotherapies, Inc. is dedicated to the development of better cancer treatment and diagnosis.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Peptor
A biopharmaceutical company engaged in discovery and development of immunotherapeutic drugs to treat diabetes
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. discovers and develops novel small molecule therapeutics that modulate nuclear receptors.
Zenha Therapeutics
Zenha Therapeutics develops a small molecule targeting microbiome to treat chronic diseases.
More informations about "Galileo Pharmaceuticals"
Galileo Pharmaceuticals Inc Information
Galileo Pharmaceuticals, Inc. is focused on the discovery and development of small molecule therapeutics to treat metabolic diseases and other disorders mediated by inflammation. We โฆSee details»
Galileo Pharmaceuticals Inc - Company Profile and News
Galileo Pharmaceuticals, Inc. provides research and development services. The Company discovers and develops small molecule therapeutics to treat metabolic and inflammatory โฆSee details»
Galileo Pharmaceuticals - Products, Competitors, Financials, โฆ
About Galileo Pharmaceuticals. Galileo Pharmaceuticals is a Healthcare/Pharmaceuticals / Drugs company based in Santa Clara, California. Galileo Pharmaceuticals' investors include Adams โฆSee details»
Galileo Pharmaceuticals, Inc. - VentureRadar
Galileo Pharmaceuticals, Inc. VentureRadar profile. Find out more about Galileo Pharmaceuticals, Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more. โฆSee details»
Galileo Pharmaceuticals - 2025 Company Profile - Tracxn
Mar 28, 2025 Galileo Pharmaceuticals is a deadpooled company based in Santa Clarita (United States), founded in 1997. It operates as a Redox pathway targeting small molecule drugs for โฆSee details»
Galileo Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Galileo Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 6 literature, Drug:GLI-8545, GLI-7006.See details»
GALILEO PHARMACEUTICALS, INC - CAGE.report
Apr 16, 2005 GALILEO PHARMACEUTICALS, INC DUNS 867797284 / 86-779-7284. NCAGE Code: 33VH8. GALILEO PHARMACEUTICALS INC. CAGE Code: 33VH8. GALILEO โฆSee details»
Galileo Pharmaceuticals Inc Company Profile, Financial and
Galileo Pharmaceuticals, Inc. discovers and develops small molecule therapeutics to treat metabolic and inflammatory diseases. The company develops a pipeline of treatments for โฆSee details»
Galileo Pharmaceuticals - Drug pipelines, Patents, Clinical trials ...
Explore Galileo Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 1 literature. Biomedical products. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign โฆSee details»
Galileo closes $31M financing - Pharmaceutical industry news | The ...
May 4, 2003 Galileo closes $31M financing 4 May 2003 Privately-held US biotechnology company Galileo Pharmaceuticals, whichis focused on drug development targeting redox โฆSee details»
Galileo Pharmaceuticals, Inc.:Company Profile & Technical โฆ
Galileo Pharmaceuticals, Inc. is headquartered in United States California. Galileo Pharmaceuticals, Inc. was founded in 1998. Galileo Pharmaceuticals, Inc. has a total of 92 โฆSee details»
Galileo Pharmaceuticals Inc. - BioCentury Company Profiles - BCIQ
Galileo Pharmaceuticals Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Galileo Pharmaceuticals - Raised $31M Funding from 7 investors
Mar 9, 2025 Galileo Pharmaceuticals has raised a total funding of $31M over 1 round from 7 investors. Investors include Tekla Capital Management, Bay City Capital and 5 others. Their โฆSee details»
Galileo Pharmaceuticals Company Profile | Management and
Galileo Pharmaceuticals Inc is a company that operates in the Pharmaceuticals industry. It employs 21-50 people and has $5M-$10M of revenue. Popular Searches. Galileo โฆSee details»
Galileo Pharmaceuticals - Crunchbase
Galileo Pharmaceuticals, Inc. is focused on the discovery and development of small molecule therapeutics to treat metabolic diseases Search Crunchbase Start Free TrialSee details»
Galileo Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
Organization. Galileo Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by Aberdeen โฆSee details»
Galileo Gets $31M To Advance Internal, Partnered Programs
May 2, 2003 Galileo Pharmaceuticals Inc. is using a $31 million boost from a preferred stock offering to advance business and drug development efforts. The Santa Clara, Calif.-based โฆSee details»
Galileo Pharmaceuticals - CB Insights
Explore {Galileo Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Galileo โฆSee details»
Galileo Pharmaceuticals: Drug pipelines, Patents, Clinical trials
Aug 2, 2023 Explore Galileo Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 2 literature. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for โฆSee details»
The Mercury Release of Galileoโข Signals a New Era for Intelligent ...
Apr 9, 2025 Hereโs whatโs new. The New Reasoning Model: Galileo Becomes A Consultant. This new release, which is available to all Galileo users, includes a major upgrade to the AI engine, โฆSee details»